Retour
Fourchette du Jour
6,12 €
6,50 €
Fourchette 52 Semaines
3,50 €
23,20 €
Volume
2 538 353
Moyenne 50J / 200J
7,86 €
/
9,48 €
Clôture Précédente
6,21 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,2 | 0,4 |
| P/B | 0,3 | 2,9 |
| ROE % | -88,7 | 3,7 |
| Net Margin % | -266,3 | 3,8 |
| Rev Growth 5Y % | 16,1 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 16,13% annually over 5 years — strong growth
Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -174,98M
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,29%
Capital efficient — spends only 4,01% of revenue on capex
Croissance
Revenue Growth (5Y)
16,13%
Revenue (1Y)4,84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-88,71%
ROIC-93,03%
Net Margin-266,25%
Op. Margin-277,93%
Sécurité
Debt / Equity
0,22
Current Ratio2,46
Interest Coverage-55,23
Valorisation
P/E Ratio
-0,22
P/B Ratio0,31
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,84% | Revenue Growth (3Y) | 15,51% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,13B | Net Income (TTM) | -3,00B |
| ROE | -88,71% | ROA | -103,31% |
| Gross Margin | 29,29% | Operating Margin | -277,93% |
| Net Margin | -266,25% | Free Cash Flow (TTM) | -174,98M |
| ROIC | -93,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 2,46 |
| Interest Coverage | -55,23 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -0,22 | P/B Ratio | 0,31 |
| P/S Ratio | 0,58 | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 653,05M | Enterprise Value | 799,97M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,13B | 1,07B | 844,72M | 792,12M | 619,67M |
| Net Income | -3,00B | -333,80M | -1,96B | -601,05M | -443,75M |
| EPS (Diluted) | -33,80 | -4,50 | -31,70 | -11,30 | -15,10 |
| Gross Profit | 330,11M | 304,33M | 197,95M | 147,26M | 148,77M |
| Operating Income | -3,13B | -238,10M | -1,84B | -769,46M | -159,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,90B | 5,91B | 5,92B | 6,87B | 6,03B |
| Total Liabilities | 860,49M | 1,22B | 1,44B | 1,27B | 1,56B |
| Shareholders' Equity | 2,07B | 4,69B | 4,47B | 5,55B | 4,46B |
| Total Debt | 451,09M | 527,75M | 794,89M | 786,36M | 938,66M |
| Cash & Equivalents | 304,17M | 311,13M | 278,33M | 524,29M | 488,47M |
| Current Assets | 944,93M | 923,43M | 1,04B | 1,01B | 883,61M |
| Current Liabilities | 384,63M | 407,64M | 583,21M | 353,39M | 401,24M |